-
Gold Kidney Health Plan entering Florida Medicare Advantage market
Gold Kidney Health Plan, a Medicare Advantage insurer offering chronic special needs plans, is expanding to Florida in 2024. -
BCBS Minnesota unearths two time capsules at its headquarters
As Blue Cross and Blue Shield of Minnesota prepares to move out of its suburban Minneapolis headquarters, the company has discovered two time capsules buried underneath the building, Twin Cities Pioneer Press reported July 11. -
Most patients stop taking weight loss drugs after 1 year: Report
About two-thirds of patients who take popular weight loss drugs end their regimen within a year, according to a Prime Therapeutics study released July 11. -
Cigna settles allegations of overcharging for lab services for $300K
Cigna has received final approval from a federal court in Connecticut on a $300,000 class settlement with plaintiffs who alleged the company violated its fiduciary duties under ERISA by overcharging for laboratory services from certain providers. -
Cigna's behavioral health network grew 30% in 2022
The Cigna Group's network of behavioral health providers grew by more than 30 percent in 2022, according to the company's 2022 Environmental, Social, and Governance Report. -
ACA risk adjustment payments are on the rise: CMS
Total risk adjustment payments in individual and small group insurance plans increased in 2022, according to new data from CMS. -
Cigna follows Optum in adding more Humira biosimilars to formulary
Cigna is adding three Humira biosimilars to its formulary beginning Sept. 1. -
Demand for Ozempic, other GLP-1 drugs contributing to rising premiums in Michigan
GLP-1 drugs like Ozempic and Wegovy are contributing to increasing premium rates in Michigan's small-group and individual insurance markets, the Detroit Free-Press reported July 10. -
BCBS Tennessee reports $22M income in 2022
BlueCross BlueShield of Tennessee reported $21.8 million in net income for 2022, down from $521.1 million in 2021. -
Leqembi could cost Medicare up to $17.8B
Leqembi, the newly-approved drug that can slow the progression of Alzhemier's disease, will cost Medicare billions each year, according to an analysis from KFF. -
Cigna beats class-action bid alleging it overcharged for medical equipment
A federal judge in Connecticut has denied a class-action bid against Cigna for allegedly overcharging members for medical equipment and violating its fiduciary duties under the Employee Retirement Income Security Act. -
Judge temporarily blocks Aetna Medicare Advantage plan for NYC retirees
A New York judge has temporarily blocked New York City's plan to switch 250,000 retired city employees from traditional Medicare to an Aetna Medicare Advantage plan. -
Independence Blue Cross, Sun Life partner on stop-loss insurance
Independence Blue Cross is partnering with financial services firm Sun Life to offer stop loss insurance to its self-funded group customers. -
UnitedHealth Group in the headlines: 11 updates
From its Optum arm striking a deal to acquire Amedisys, to a warning of rising medical costs, here are 11 updates from UnitedHealth Group that Becker's has reported since June 13: -
Many Medicare Advantage beneficiaries report financial instability, food insecurity, Humana report finds
Nearly half of Medicare Advantage beneficiaries report having at least one health-related social need, a study published in the July issue of Health Affairs found. -
Payers ranked by Medicaid managed care market share
Five publicly traded companies have 50 percent of the Medicaid-managed care market, according to a July 6 analysis from KFF. -
Employers are increasingly suing their health plan for claims data
Lawsuits from large companies and employers are increasingly being filed against third-party health plan administrators in an effort to access complete employee medical claims data. -
3 reactions to Biden's proposed 'junk' health insurance crackdown
The Biden administration issued proposed rules July 7 that aimed to crack down on "junk" short-term health insurance plans. -
HHS: Medicare Part D enrollees will save $400 on average in 2025
Caps on Medicare prescription drug costs will save Part D enrollees a collective $7.4 billion in 2025, according to a report from HHS' Office of the Assistant Secretary for Planning and Evaluation. -
How Priority Health has reduced emergency room visits during pregnancy by 16%
Over the last two years, Priority Health's maternity management program, "PriorityMOM," has achieved a 16 percent decrease in emergency room visits for pregnant members who may experience complications pre- or post-delivery.
Page 46 of 50